- Home
- GRX vs OVID Comparison
GRX vs OVID Comparison
Compare GRX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- OVID
- Stock Information
- Founded
- GRX 2007
- OVID 2014
- Country
- GRX United States
- OVID United States
- Employees
- GRX N/A
- OVID N/A
- Industry
- GRX Finance/Investors Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- OVID Health Care
- Exchange
- GRX Nasdaq
- OVID Nasdaq
- Market Cap
- GRX 142.7M
- OVID 117.3M
- IPO Year
- GRX N/A
- OVID 2017
- Fundamental
- Price
- GRX $9.23
- OVID $1.43
- Analyst Decision
- GRX
- OVID Strong Buy
- Analyst Count
- GRX 0
- OVID 4
- Target Price
- GRX N/A
- OVID $3.13
- AVG Volume (30 Days)
- GRX 39.7K
- OVID 5.1M
- Earning Date
- GRX 01-01-0001
- OVID 11-13-2025
- Dividend Yield
- GRX 5.98%
- OVID N/A
- EPS Growth
- GRX N/A
- OVID N/A
- EPS
- GRX 0.26
- OVID N/A
- Revenue
- GRX N/A
- OVID $6,651,000.00
- Revenue This Year
- GRX N/A
- OVID $1,086.57
- Revenue Next Year
- GRX N/A
- OVID N/A
- P/E Ratio
- GRX $38.50
- OVID N/A
- Revenue Growth
- GRX N/A
- OVID 1070.95
- 52 Week Low
- GRX $7.73
- OVID $0.24
- 52 Week High
- GRX $10.40
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- GRX 48.46
- OVID 44.93
- Support Level
- GRX $9.23
- OVID $1.50
- Resistance Level
- GRX $9.34
- OVID $1.73
- Average True Range (ATR)
- GRX 0.10
- OVID 0.13
- MACD
- GRX 0.01
- OVID -0.04
- Stochastic Oscillator
- GRX 46.61
- OVID 4.94
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.